UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.813

Sortiert nach

Non–Small Cell Lung Cancer: Does Histology Matter?

International journal of radiation oncology, biology, physics, 2017-05, Vol.98 (1), p.227-228

2017

Link zum Volltext

Verfügbarkeit prüfen

Tiragolumab (Anti-TIGIT) in SCLC: Skyscraper-02, a Towering Inferno

Lung cancer (Auckland), 2023-01, Vol.14, p.1-9

2023

Link zum Volltext

Verfügbarkeit prüfen

A Long Overdue Targeted Treatment for KRAS Mutations in NSCLC: Spotlight on Adagrasib

Lung cancer (Auckland), 2022-01, Vol.13, p.75-80

2022

Link zum Volltext

Verfügbarkeit prüfen

ES28.04 Emerging Mechanisms to Target KRAS Directly

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S96-S97

Nagasaka, M.

2021

Link zum Volltext

Verfügbarkeit prüfen

The allure of ‘ALUR’

Annals of oncology, 2018-06, Vol.29 (6), p.1344-1346

2018

Link zum Volltext

Verfügbarkeit prüfen

Proteoglycan Expression Is Influenced by Mechanical Load in TMJ Discs

Journal of dental research, 2015-01, Vol.94 (1), p.93-100

2015

Link zum Volltext

Verfügbarkeit prüfen

559P Comprehensive survey of AACR GENIE database revealed a wide range of TMB distribution among all three classes (I, II, III) of BRAF mutated NSCLC

Annals of oncology, 2023-11, Vol.34, p.S1687-S1688

2023

Link zum Volltext

Verfügbarkeit prüfen

Proton transfer in a two-dimensional hydrogen-bonding network: water and hydroxyl on a pt(111) surface

Physical review letters, 2008-03, Vol.100 (10), p.106101-106101, Article 106101

2008

Link zum Volltext

Verfügbarkeit prüfen

485P LDCT lung cancer screening of never-smokers meta-analysis subgroup analysis: Adenocarcinoma is the highly predictive histology identified in never-smokers

Annals of oncology, 2023-11, Vol.34, p.S1651

2023

Link zum Volltext

Verfügbarkeit prüfen

PD-23 Comprehensive survey of AACR GENIE cBioPortal database of receptor tyrosine kinase fusion in colorectal carcinoma identified high co-occurring genomic alterations in NTRK1 & RET fusion-positive CRC

Annals of oncology, 2023-06, Vol.34, p.S10-S10

2023

Link zum Volltext

Verfügbarkeit prüfen

Spotlight on Cemiplimab-rwlc in the Treatment of Non-Small Cell Lung Cancer (NSCLC): Focus on Patient Selection and Considerations

Cancer management and research, 2023-01, Vol.15, p.627-634

2023

Link zum Volltext

Verfügbarkeit prüfen

MARIPOSA: Can Amivantamab and Lazertinib Replace Osimertinib in the Front-Line Setting?

Lung cancer (Auckland), 2024-01, Vol.15, p.41-47

2024

Link zum Volltext

Verfügbarkeit prüfen

Severity of Financial Toxicity for Patients Receiving Palliative Radiation Therapy

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e234-e235

2023

Link zum Volltext

Verfügbarkeit prüfen

Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer

Lung cancer (Auckland), 2021-01, Vol.12, p.133-138

2021

Link zum Volltext

Verfügbarkeit prüfen

Reaction-path switching induced by spatial-distribution change of reactants: CO oxidation on Pt(111)

The Journal of chemical physics, 2004-09, Vol.121 (11), p.5035-5038

2004

Link zum Volltext

Verfügbarkeit prüfen

The Butterfly Flies - Practice Changing Results of PAPILLON, First Line Chemotherapy and Amivantamab for the Treatment of NSCLC Patients with EGFR Exon 20 Insertions

Lung cancer (Auckland), 2024-01, Vol.15, p.49-54

2024

Link zum Volltext

Verfügbarkeit prüfen

Folded-type rectangular loop antenna with tunable circuit

Electronics letters, 2010, Vol.46 (1), p.19-21

2010

Link zum Volltext

Verfügbarkeit prüfen

Deconstructing ADAURA. It is Not Yet Time to Forgo Platinum-based Adjuvant Chemotherapy in Resected Early Stage (IB-IIIA) EGFR-mutant NSCLC

Lung cancer (Auckland), 2022-05, Vol.13, p.47-52

2022

Link zum Volltext

Verfügbarkeit prüfen

Spotlight on Patritumab Deruxtecan (HER3-DXd) from HERTHENA Lung01. Is a Median PFS of 5.5 Months Enough in Light of FLAURA-2 and MARIPOSA?

Lung cancer (Auckland), 2024-07, Vol.15, p.115-121

2024

Link zum Volltext

Verfügbarkeit prüfen

P2.09-09 A Phase 1, 2 Study to Evaluate the Safety and Anti-tumor Activity of JIN-A02 in Patients with EGFR Mutant Advanced NSCLC

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S335

2023

Link zum Volltext

Verfügbarkeit prüfen

597TiP A phase I/II study to evaluate the safety and anti-tumor activity of JIN-A02 in patients with EGFR TKI-refractory, EGFR-mutant advanced NSCLC

Annals of oncology, 2023-11, Vol.34, p.S1704-S1705

2023

Link zum Volltext

Verfügbarkeit prüfen

The Nail in the Coffin?: Examining the KEYNOTE-789 Clinical Trial's Impact

Lung cancer (Auckland), 2024-01, Vol.15, p.1-8

2024

Link zum Volltext

Verfügbarkeit prüfen

Spotlight on Sotorasib (AMG 510) for KRASG12C Positive Non-Small Cell Lung Cancer

Lung cancer (Auckland), 2021-10, Vol.12, p.115-122

2021

Link zum Volltext

Verfügbarkeit prüfen

86P Adjusting ORIENT-11 trial (O-11) results to a US patient population

Annals of oncology, 2021-12, Vol.32, p.S1409-S1410

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.813

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.406)
Mit Volltextzugriff
(1.572)

Publikationsform

Sprache

Englisch
(1.633)
Japanisch
(540)
Französisch
(4)
Deutsch
(4)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Physical Review Letters
(128)
Annals Of Oncology
(53)
Journal Of Nuclear Materials
(32)
Journal Of Thoracic Oncology
(30)
Transplantation Proceedings
(26)
Isij International
(24)
Diabetes Care
(23)
Tetsu To Hagane
(23)
Japanese Journal Of Applied Physics
(22)
Lung Cancer
(22)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Non–Small Cell Lung Cancer: Does Histology Matter?

Tiragolumab (Anti-TIGIT) in SCLC: Skyscraper-02, a Towering Inferno

A Long Overdue Targeted Treatment for KRAS Mutations in NSCLC: Spotlight on Adagrasib

ES28.04 Emerging Mechanisms to Target KRAS Directly

The allure of ‘ALUR’

Proteoglycan Expression Is Influenced by Mechanical Load in TMJ Discs

559P Comprehensive survey of AACR GENIE database revealed a wide range of TMB distribution among all three classes (I, II, III) of BRAF mutated NSCLC

Proton transfer in a two-dimensional hydrogen-bonding network: water and hydroxyl on a pt(111) surface

485P LDCT lung cancer screening of never-smokers meta-analysis subgroup analysis: Adenocarcinoma is the highly predictive histology identified in never-smokers

PD-23 Comprehensive survey of AACR GENIE cBioPortal database of receptor tyrosine kinase fusion in colorectal carcinoma identified high co-occurring genomic alterations in NTRK1 & RET fusion-positive CRC

Spotlight on Cemiplimab-rwlc in the Treatment of Non-Small Cell Lung Cancer (NSCLC): Focus on Patient Selection and Considerations

MARIPOSA: Can Amivantamab and Lazertinib Replace Osimertinib in the Front-Line Setting?

Severity of Financial Toxicity for Patients Receiving Palliative Radiation Therapy

Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer

Reaction-path switching induced by spatial-distribution change of reactants: CO oxidation on Pt(111)

The Butterfly Flies - Practice Changing Results of PAPILLON, First Line Chemotherapy and Amivantamab for the Treatment of NSCLC Patients with EGFR Exon 20 Insertions

Folded-type rectangular loop antenna with tunable circuit

Deconstructing ADAURA. It is Not Yet Time to Forgo Platinum-based Adjuvant Chemotherapy in Resected Early Stage (IB-IIIA) EGFR-mutant NSCLC

Spotlight on Patritumab Deruxtecan (HER3-DXd) from HERTHENA Lung01. Is a Median PFS of 5.5 Months Enough in Light of FLAURA-2 and MARIPOSA?

P2.09-09 A Phase 1, 2 Study to Evaluate the Safety and Anti-tumor Activity of JIN-A02 in Patients with EGFR Mutant Advanced NSCLC

Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry

597TiP A phase I/II study to evaluate the safety and anti-tumor activity of JIN-A02 in patients with EGFR TKI-refractory, EGFR-mutant advanced NSCLC

The Nail in the Coffin?: Examining the KEYNOTE-789 Clinical Trial's Impact

Spotlight on Sotorasib (AMG 510) for KRASG12C Positive Non-Small Cell Lung Cancer

86P Adjusting ORIENT-11 trial (O-11) results to a US patient population

Suchergebnisse filtern